Literature DB >> 12011101

Combinatorial ganglioside biosynthesis.

Thomas Kolter1, Richard L Proia, Konrad Sandhoff.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12011101     DOI: 10.1074/jbc.R200001200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


× No keyword cloud information.
  92 in total

1.  Metabolic cytometry: capillary electrophoresis with two-color fluorescence detection for the simultaneous study of two glycosphingolipid metabolic pathways in single primary neurons.

Authors:  David C Essaka; Jillian Prendergast; Richard B Keithley; Monica M Palcic; Ole Hindsgaul; Ronald L Schnaar; Norman J Dovichi
Journal:  Anal Chem       Date:  2012-03-07       Impact factor: 6.986

Review 2.  Sphingolipid and glycosphingolipid metabolic pathways in the era of sphingolipidomics.

Authors:  Alfred H Merrill
Journal:  Chem Rev       Date:  2011-09-26       Impact factor: 60.622

3.  Molecular Microscopy of Brain Gangliosides: Illustrating their Distribution in Hippocampal Cell Layers.

Authors:  Benoit Colsch; Shelley N Jackson; Sucharita Dutta; Amina S Woods
Journal:  ACS Chem Neurosci       Date:  2011-02-21       Impact factor: 4.418

4.  Interruption of ganglioside synthesis produces central nervous system degeneration and altered axon-glial interactions.

Authors:  Tadashi Yamashita; Yun-Ping Wu; Roger Sandhoff; Norbert Werth; Hiroki Mizukami; Jessica M Ellis; Jeffrey L Dupree; Rudolf Geyer; Konrad Sandhoff; Richard L Proia
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-14       Impact factor: 11.205

5.  Essential roles of neutral ceramidase and sphingosine in mitochondrial dysfunction due to traumatic brain injury.

Authors:  Sergei A Novgorodov; Christopher L Riley; Jin Yu; Keith T Borg; Yusuf A Hannun; Richard L Proia; Mark S Kindy; Tatyana I Gudz
Journal:  J Biol Chem       Date:  2014-03-21       Impact factor: 5.157

Review 6.  Glycan evolution in response to collaboration, conflict, and constraint.

Authors:  Stevan A Springer; Pascal Gagneux
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

7.  New Insights on Non-Enzymatic Oxidation of Ganglioside GM1 Using Mass Spectrometry.

Authors:  Daniela Couto; Tânia Melo; Elisabete Maciel; Ana Campos; Eliana Alves; Sofia Guedes; M Rosário M Domingues; Pedro Domingues
Journal:  J Am Soc Mass Spectrom       Date:  2016-08-30       Impact factor: 3.109

8.  GM2/GD2 and GM3 gangliosides have no effect on cellular cholesterol pools or turnover in normal or NPC1 mice.

Authors:  Hao Li; Stephen D Turley; Benny Liu; Joyce J Repa; John M Dietschy
Journal:  J Lipid Res       Date:  2008-04-30       Impact factor: 5.922

9.  Gangliosides and beta1-integrin are required for caveolae and membrane domains.

Authors:  Raman Deep Singh; David L Marks; Eileen L Holicky; Christine L Wheatley; Tatiana Kaptzan; Satoshi B Sato; Toshihide Kobayashi; Kun Ling; Richard E Pagano
Journal:  Traffic       Date:  2009-12-03       Impact factor: 6.215

Review 10.  Targeting Glycosphingolipid Metabolism to Treat Kidney Disease.

Authors:  James A Shayman
Journal:  Nephron       Date:  2016-03-09       Impact factor: 2.847

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.